Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

No reported Revenue figures are available to summarize.

Revenue history

Currency unavailable · from the income statement

No Revenue data reported for this period type.

Revenue vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Revenue for ODTX and competitors
Company Period LTM YoY 3-year CAGR
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$281.99M USD+34.8%+20.1%
ANABAnaptysBio, Inc.LTM Mar 2026$232.39M USD+107.7%+183.6%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$90.49M USD——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$8.37M USD-52.9%-35.9%
ALMSAlumis Inc. Common StockLTM Jun 2026$7.4M USD-63.1%—
ORKAOruka Therapeutics, Inc.LTM Sep 2026$0 USD——
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024€0 EUR——
IMUXImmunic, Inc.LTM Mar 2026$0 USD——
ODTXOdyssey Therapeutics, Inc.—— ——
Peer median (excluding ODTX) —-9.1%+20.1%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.